Trian Fund Management, L.P. 13F holdings and portfolio analysis
Melden Sie sich an, um einen neuen Zweig aus dem ausgewählten Plan zu klonen und dann im neuen Zweig weiter zu optimieren.
Baseline
Analyse-NachrichtenVorbereitete Q&A zu diesem Fonds. Als Referenzkontext für Ihre eigene Analyse verwenden.
Directly following the baseline means accepting a highly concentrated six-name portfolio. In the strategy artifact, top five holdings are 99.99% and the top two alone are 73.91% through JHG at 40.63% and GE at 33.28%. Sector exposure is also narrow, with 42.72% Financials, 39.77% Industrials, and 17.51% Health Care. The backtest still generated 7.74% annualized return and 104.72% total return, but investors took a -33.02% max drawdown and negative -1.05 alpha versus SPY.
Three recent periods summarize the trade-off well. 2024-03-31 was the weakest, with -8.56% optimized return versus 2.31% for SPY, a -10.87% excess return, showing how painful concentration can be in the wrong quarter. 2023-09-30 was one of the best, with 15.47% return versus 10.11% for SPY and 5.37% excess return, but turnover was high at 54.64. More recently, 2025-03-31 returned 9.77% versus 9.22% for SPY and 2025-06-30 returned 5.15% versus 4.2%, showing the baseline can still keep up when its core holdings work.
A user should inspect concentration, implementation lag, and the worst drawdown path next. The baseline artifact flags 99.99% in the top five, 272 trades, and 1.4906 total estimated cost, while risk notes explicitly warn that filing-delay replication may reduce real-world results. It is also worth checking turnover spikes such as 63.15 on 2024-06-30 and 54.64 on 2023-09-30, because those periods likely changed exposure meaningfully. If those concentration and lag risks are not acceptable, the baseline probably is not the right choice despite its lower 0.69 beta.